Clinical Studies of Histone Deacetylase Inhibitors
H. Miles Prince(Monash University), Simon J. Harrison(The University of Melbourne), Mark Bishton(Peter MacCallum Cancer Centre)
Cited by 356
Related Papers
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719
Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
|Journal of Clinical Oncology|2011|657